Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recent advances in the treatment of IBD: Targets, mechanisms and related therapies
Juan Liu, Bin Di, Lili Xu
Cytokine & Growth Factor Reviews (2023) Vol. 71-72, pp. 1-12
Closed Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Polyphenolic Nanoparticle-Modified Probiotics for Microenvironment Remodeling and Targeted Therapy of Inflammatory Bowel Disease
Qinglian Hu, Jingyu Li, Tong Wang, et al.
ACS Nano (2024) Vol. 18, Iss. 20, pp. 12917-12932
Closed Access | Times Cited: 17
Ulcerative colitis: clinical biomarkers, therapeutic targets, and emerging treatments
Phurpa Wangchuk, Karma Yeshi, Alex Loukas
Trends in Pharmacological Sciences (2024)
Closed Access | Times Cited: 13
Fucoxanthin Alleviates Dextran Sulfate Sodium-Induced Colitis and Gut Microbiota Dysbiosis in Mice
Yuhong Yang, Chen Chen, Yan Zheng, et al.
Journal of Agricultural and Food Chemistry (2024) Vol. 72, Iss. 8, pp. 4142-4154
Closed Access | Times Cited: 9
Biomarkers in inflammatory bowel disease: a practical guide
Jennifer Clough, Michael Colwill, Andrew Poullis, et al.
Therapeutic Advances in Gastroenterology (2024) Vol. 17
Open Access | Times Cited: 8
Pharmacological Therapy in Inflammatory Bowel Diseases: A Narrative Review of the Past 90 Years
Marcello Imbrizi, Fernando Magro, Cláudio Saddy Rodrigues Coy
Pharmaceuticals (2023) Vol. 16, Iss. 9, pp. 1272-1272
Open Access | Times Cited: 18
Cellular and Molecular Determinants of Biologic Drugs Resistance and Therapeutic Failure in Inflammatory Bowel Disease
Pierluigi Puca, I. Capobianco, Gaetano Coppola, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2789-2789
Open Access | Times Cited: 6
Genetic Variants Associated with Biological Treatment Response in Inflammatory Bowel Disease: A Systematic Review
Javier Plaza Zamora, Alejandro Mínguez, Guillermo Bastida, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3717-3717
Open Access | Times Cited: 6
Wogonin improves colitis by activating the AhR pathway to regulate the plasticity of ILC3/ILC1
Qiujuan Ye, Shaowei Huang, Ying Wang, et al.
Phytomedicine (2024) Vol. 128, pp. 155425-155425
Closed Access | Times Cited: 5
Discovery of 7-Azaindole Inhibitors of Inflammasomes/Il-1β for the Treatment of Inflammatory Bowel Disease
Yuyun Yan, Xiuxiu Zhang, Ruiwen Wu, et al.
(2025)
Closed Access
Injectable DAT-ALG Hydrogel Mitigates Senescence of Loaded DPMSCs and Boosts Healing of Perianal Fistulas in Crohn’s Disease
Hanxu Gao, Dajun Xing, Menglong Wu, et al.
ACS Biomaterials Science & Engineering (2025)
Closed Access
Screen of propionate-producing probiotic strains in attenuating murine colitis by modulating immune response and restoring the intestinal barrier
Ting Shu, Xizi Song, Silu Zhang, et al.
Journal of Functional Foods (2025) Vol. 125, pp. 106660-106660
Closed Access
Chemical Composition of Cynanchum auriculatum Royle Ex Wight and Its Potential Role in Ameliorating Colitis
S. J. Li, Yuning Sun, Huihui Peng, et al.
Food Science & Nutrition (2025) Vol. 13, Iss. 1
Open Access
Correlation and diagnostic significance of CD4 T cell subsets and NLRP3 inflammasome in ulcerative colitis: the role of the NLRP3/T-bet/GATA3 axis
Yingnan Hu, Jingyi Tang, Dian Yu, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Cynaroside ameliorates TNBS-induced colitis by inhibiting intestinal epithelial cell apoptosis via the PI3K/AKT signalling pathway
Ju Huang, Jing Li, Zhijun Geng, et al.
Frontiers in Pharmacology (2025) Vol. 15
Open Access
SAA3 deficiency exacerbates intestinal fibrosis in DSS-induced IBD mouse model
Xiaodong Zou, Tong Tong Wu, Jianjiao Lin, et al.
Cell Death Discovery (2025) Vol. 11, Iss. 1
Open Access
Interprofessional approach to personalized medication management and therapy optimization in IBD care
Daniel F. Fleischmann, Benedicta Binder, Muriel Huss, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review
Octavio Ballesta‐López, M Gil Candel, María Centelles-Oria, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1760-1760
Open Access
Oral colon-targeted delivery of recombinant human MANF for alleviation of ulcerative colitis
JieZhou, Tianle Li, Bowei, et al.
International Journal of Pharmaceutics X (2025), pp. 100320-100320
Open Access
Proteomic analysis reveals that Acalypha australis L. mitigates chronic colitis by modulating the FABP4/PPARγ/NF-κB signaling pathway
Xia-Jie Quan, Zhiwei Miao, Renji Han, et al.
Journal of Ethnopharmacology (2025), pp. 119585-119585
Closed Access
Musa basjoo Sieb polysaccharide improves inflammation in RAW264.7 cells and zebrafish colitis
Yan Zhang, Chenchen Zhang, Manhong Luo, et al.
Food Bioscience (2024) Vol. 61, pp. 104471-104471
Closed Access | Times Cited: 4
Design strategies, advances and future perspectives of colon-targeted delivery systems for the treatment of inflammatory bowel disease
Baoxin Zheng, Liping Wang, Yan Yi, et al.
Asian Journal of Pharmaceutical Sciences (2024) Vol. 19, Iss. 4, pp. 100943-100943
Open Access | Times Cited: 4
Current Treatments, Emerging Therapeutics, and Natural Remedies for Inflammatory Bowel Disease
Karma Yeshi, Tenzin Jamtsho, Phurpa Wangchuk
Molecules (2024) Vol. 29, Iss. 16, pp. 3954-3954
Open Access | Times Cited: 4
Development of 3D-Printed Bicompartmental Devices by Dual-Nozzle Fused Deposition Modeling (FDM) for Colon-Specific Drug Delivery
Fatemeh Shojaie, C Ferrero, Isidoro Caraballo
Pharmaceutics (2023) Vol. 15, Iss. 9, pp. 2362-2362
Open Access | Times Cited: 11
Preventive Effect of <em>Ecklonia cava</em> Extract on Dss-Induced Colitis by Elevating Intestinal Barrier Function and Improving Pathogenic Inflammation
Youngmi Kim, Hye-Youn Kim, Ji Tae Jang, et al.
(2023)
Open Access | Times Cited: 11
Gut-tropic T cells and extra-intestinal autoimmune diseases
Yutong Wu, Qiaolin Wang, Sujie Jia, et al.
Autoimmunity Reviews (2024) Vol. 23, Iss. 7-8, pp. 103544-103544
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top